David Kung

David Kung

Auto-generated profile, based on publicly available information

David Kung

Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2021 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Open access
PDF file
BJBrian T Jankowitz
Brian T Jankowitz
AJAshutosh P Jadhav
Ashutosh P Jadhav
BGBradley Gross
Bradley Gross
TJTudor G Jovin
Tudor G Jovin
AAAbdulnasser A Alhajeri
Abdulnasser A Alhajeri
OZOsama O Zaidat
Osama O Zaidat
Background: Stent-assisted coiling of wide-necked intracranial aneurysms (IAs) using the Neuroform Atlas Stent System (Atlas) has shown promising results. Objective: To present the primary efficacy and safety results of the ATLAS Investigational Device Exemption (IDE) trial in a cohort of patients with posterior circulation IAs. Methods: The ATLAS trial is a prospective, multicenter, single-arm, open-label study of unruptured, wide-necked, IAs treated with the Atlas stent and adjunctive coiling. This study reports the results of patients with posterior circulation IAs. The primary efficacy endpoint was complete aneurysm occlusion (Raymond-Roy (RR) class I) on 12-month angiography, in the absence of re-treatment or parent artery stenosis >50%. The primary safety endpoint was any major ipsilateral stroke or neurological death within 12 months. Adjudication of the primary endpoints was performed by an imaging core laboratory and a Clinical Events Committee. Results: The ATLAS trial enrolled and treated 116 patients at 25 medical centers with unruptured, wide-necked, posterior circulation IAs (mean age 60.2±10.5 years, 81.0% (94/116) female). Stents were placed in all patients with 100% technical success rate. A total of 95/116 (81.9%) patients had complete angiographic follow-up at 12 months, of whom 81 (85.3%) had complete aneurysm occlusion (RR class I). The primary effectiveness outcome was achieved in 76.7% (95% CI 67.0% to 86.5%) of patients. Overall, major ipsilateral stroke and secondary persistent neurological deficit occurred in 4.3% (5/116) and 1.7% (2/116) of patients, respectively. Conclusions: In the ATLAS IDE posterior circulation cohort, the Neuroform Atlas Stent System with adjunctive coiling demonstrated high rates of technical and safety performance. Trial registration number https://clinicaltrials.gov/ct2/show/NCT02340585.

1 January 2019 in World Neurosurgery
Verified
Journal Article
Closed access
MZMario Zanaty
Mario Zanaty
ESEdgar A Samaniego
Edgar A Samaniego
NTNahom Teferi
Nahom Teferi
DKDavid K. Kung
David K. Kung
DNDaichi Nakagawa
Daichi Nakagawa
DHDavid Hasan
David Hasan

11 July 2020 in Interdisciplinary Neurosurgery
Verified
Journal Article
Open access
MCMougnyan Cox
Mougnyan Cox
PRPreethi Ramchand
Preethi Ramchand
RMRaghav Mattay
Raghav Mattay
NSNeda I. Sedora-Roman
Neda I. Sedora-Roman
DKDavid Kung
David Kung
OCOmar Choudhri
Omar Choudhri
Cervical carotid artery dissections (CAD) usually produce ischemic symptoms as a result of thromboembolic phenomena, but hemodynamic insufficiency from flow-limiting stenosis can cause symptoms in a few patients [1]. CAD of the distal cervical and petrous ICA can be challenging to treat, particularly in the presence of vessel kinking or marked tortuosity of the distal cervical ICAs. The carotid stent systems used for atherosclerotic disease at the proximal ICA or carotid bulb are typically too stiff and large to safely track into a tortuous distal carotid artery, and the low radial force of the Pipeline flow diverter may occasionally result in inadequate flow restoration and even stent collapse in flow-limiting carotid dissections with large intramural thrombus burden [2,3]. In this paper, via 2 illustrative cases, we detail our experience with the latest iteration of the Neuroform stent system, the Neuroform Atlas (Stryker Neurovascular, Freemont, CA), for treatment of symptomatic flow-limiting distal cervical ICA dissections, with an emphasis on the advantages of the updated stent design.

7 August 2017 in arXiv
Verified
Preprint
Open access
PDF file
MCMinsik Cho
Minsik Cho
UFUlrich Finkler
Ulrich Finkler
SKSameer Kumar
Sameer Kumar
DKDavid Kung
David Kung
VSVaibhav Saxena
Vaibhav Saxena
DSDheeraj Sreedhar
Dheeraj Sreedhar
As deep neural networks become more complex and input datasets grow larger, it can take days or even weeks to train a deep neural network to the desired accuracy. Therefore, distributed Deep Learning at a massive scale is a critical capability, since it offers the potential to reduce the training time from weeks to hours. In this paper, we present a software-hardware co-optimized distributed Deep Learning system that can achieve near-linear scaling up to hundreds of GPUs. The core algorithm is a multi-ring communication pattern that provides a good tradeoff between latency and bandwidth and adapts to a variety of system configurations. The communication algorithm is implemented as a library for easy use. This library has been integrated into Tensorflow, Caffe, and Torch. We train Resnet-101 on Imagenet 22K with 64 IBM Power8 S822LC servers (256 GPUs) in about 7 hours to an accuracy of 33.8 % validation accuracy. Microsoft's ADAM and Google's DistBelief results did not reach 30 % validation accuracy for Imagenet 22K. Compared to Facebook AI Research's recent paper on 256 GPU training, we use a different communication algorithm, and our combined software and hardware system offers better communication overhead for Resnet-50. A PowerAI DDL enabled version of Torch completed 90 epochs of training on Resnet 50 for 1K classes in 50 minutes using 64 IBM Power8 S822LC servers (256 GPUs).